-
FTC Announces New HSR Filing Fees Of Up to $2.25 Million and Revised HSR Thresholds for 2023 (January 25, 2023)
- In Law360, Paul Tropp Analyzes Slowdown in SPAC IPOs (May 6, 2021)
- PErspectives: Private Equity Industry Insights | Spring 2021 (April 9, 2021)
- Special Report - Peak Performance: Challenges and Opportunities in Post COVID-19 Credit Fund Platforms
- Event: Navigating Life Sciences M&A Under the Biden Administration | Drug Pricing & Antitrust Considerations (March 25, 2021)
- American Rescue Plan Act of 2021– Summary of Key Provisions (March 25, 2021)
- Event: Outlook 2021 – Washington, D.C. Updates and Insights on Life Sciences and Health Care (February 25, 2021)
- In Law360, Margaux Hall Examines Drug Commercialization and Market Access Strategies in Light of Drug Pricing Regulatory Uncertainty Under the Biden Administration (February 16, 2021)
- FTC, DOJ Announce Suspension of HSR Early Termination (February 8, 2021)
- Private Funds Report, Volume 1 – 2020 Year in Review And A Look Ahead (January 29, 2021)
- Bipartisan Proposal for Extension and Revision of Coronavirus Aid, Relief, and Economic Security Act (CARES Act) – Summary of Key Provisions (January 27, 2021)
- In Law360, Attorneys Evaluate 2021 IPO Market (January 5, 2021)
- In Law360 Tom Bulleit Analyzes 2021 Health Policies Under the Biden Administration (January 5, 2021)
- Phase 4 Stimulus Package—Highlight of Certain Key Tax-Related Provisions in the Phase 4 Stimulus Package (December 22, 2020)
- Ropes & Gray Partners Discuss ESG In The Wall Street Journal Pro Private Equity (December 18, 2020)
- Video: 2020 Election and Health Care (December 15, 2020)
Cookie Settings
